2016
DOI: 10.1007/s12170-016-0509-2
|View full text |Cite
|
Sign up to set email alerts
|

The Unchartered Frontier: Preventive Cardiology Between the Ages of 15 and 35 Years

Abstract: It is well established that atherosclerosis, the pathological basis of cardiovascular disease (CVD), begins in childhood and progresses steadily between the ages of 15 to 35 years. These adolescent and young adult years are also marked by significant physiological, psychological, and sociodemographic changes that impact both CVD risk factor development and CVD prevention and treatment strategies. In this review, we highlight the importance of the primordial prevention of CVD risk factors before they ever occur… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
1

Year Published

2019
2019
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 92 publications
0
7
1
Order By: Relevance
“…Uniformly, our patients felt they had little input on the timing of the transition. This is not inconsistent with previous published studies showing that patients are often not included in either the decision to transition or the timing [12,13]. Not including patients in the timing of transition decision may contradict the notion of the YA evolving development of self-identity and independence.…”
Section: Discussioncontrasting
confidence: 60%
“…Uniformly, our patients felt they had little input on the timing of the transition. This is not inconsistent with previous published studies showing that patients are often not included in either the decision to transition or the timing [12,13]. Not including patients in the timing of transition decision may contradict the notion of the YA evolving development of self-identity and independence.…”
Section: Discussioncontrasting
confidence: 60%
“…Our results add to accumulating evidence that young adulthood is a critical period when exposure to suboptimal BP or cholesterol is particularly harmful, and maintaining optimal levels of BP and LDL throughout young adulthood could yield substantial lifetime CVD prevention benefits (14). However, young adults are difficult to reach by way of traditional, clinic-based preventive programs: they are transitioning between pediatric and adult-centered models of care (36); they often lack health insurance or experience frequent gaps in insurance coverage (37); and their use of ambulatory medical care and adherence to preventive health guidelines are the lowest of any age group (36,38). Data from National Health and Nutrition Examination Surveys showed that young adults lagged behind in awareness, treatment, and control of high BP and LDL compared with middle-aged and older adults (39,40), and were especially unlikely to be aware of borderline levels of BP and cholesterol, which were associated with future risk of CHD and HF in our study (41).…”
Section: Discussionmentioning
confidence: 99%
“…The majority of the young adults with nonoptimal risk factors have low 10-year ASCVD risk and are not likely to receive either pharmacological interventions or advice to pursue lifestyle measures (i.e., weight loss, heart-healthy diet), if they are screened at all (4547). Pharmacological BP and LDL lowering may benefit selected young adults at high risk for premature ASCVD (36,47,48). The currently ongoing ECAD (Eliminate Coronary Artery Disease) trial is designed to address the question of whether incident ASCVD events can be more effectively prevented by early initiation of statin-based LDL lowering in young and middle-aged adults who are not yet candidates for guideline-based pharmacological LDL lowering due to low 10-year ASCVD risk (47).…”
Section: Discussionmentioning
confidence: 99%
“…79 Nevertheless, a systematic review and meta-analysis of 18 studies, providing cumulative data on 45 249 individuals, demonstrated that in utero exposure to PE is associated with higher systolic (2.39 mm Hg, 95% CI, 1.74-3.05; P < .0001) and diastolic (1.35 mm Hg, 95% CI, 0.90-1.80; P < .00001) blood pressure and increased BMI during childhood and young adulthood. 80 Because the pathological basis of CVD starts in childhood, Goodling and Johnson 81 highlighted recently the importance of primordial prevention of cardiovascular risk factors (ie, before they even occur) during childhood and assessment and primary prevention of CVD during adolescence and early adulthood. By their own admission, identifying, implementing, and disseminating effective interventions in these age groups is challenging.…”
Section: Transgenerational Hypertension and Early-onset Cvdmentioning
confidence: 99%
“…In case of adolescent PE, both the mother and child may benefit from long-term, cardiovascular risk reduction interventions, although such sustained programs are often considered beyond the scope, as well as financial means, of many health-care systems. 81 From a biological perspective, the increased incidence of placental disorders in adolescence, especially very young women, lays bare several aspects of uterine physiology that are virtually unexplored. Concepts such as "uterine immaturity," "decidual resistance," "menstrual preconditioning," and "acute endometrial senescence" are likely also relevant to the pathogenesis of other intransigent reproductive disorders, including endometriosis.…”
Section: Perspectivementioning
confidence: 99%